Table 1.

Human leukocyte antigen distribution in RSA patients from Mumbai, India

HLA	Patients (N = 81)		Controls (N = 97)		OR	EF	PF	P-value
	N+	AF (%)	N+	AF (%)
A1	40	24.69	32	16.49	1.981	0.24		0.026
A2	34	20.98	38	19.58	1.123
A3	25	15.43	9	4.63	4.365	0.23		0.0002*
A9	20	12.34	40	20.61	0.467		0.21	0.02
A10	4	2.46	9	4.63	0.507
A11	9	5.55	17	8.76	0.588
A19	22	13.58	28	14.43	0.918
A28	4	2.46	11	5.67	0.406
B5	17	10.49	23	11.85	0.854
B7	16	9.87	29	14.94	0.577
B8	4	2.46	9	4.63	0.507
B12	8	4.93	12	6.18	0.776
B13	2	1.23	4	2.06	0.588
B17	41	25.3	22	11.34	3.494	0.35		0.0001*
B22	7	4.32	7	3.6	1.216
B27	7	4.32	7	3.6	1.216
B35	22	13.58	31	15.97	0.793
B40	30	18.51	34	17.52	1.089
B44	5	3.08	2	1.03	3.125	0.04		0.159

N+ - Number positive; AF (%)- allele frequency percentage; OR - Odds ratio; EF - Etiological fraction; PF-Preventive fraction

^*Significant P-value